TNF and colitis: Other studies have evaluated the roles of immunosuppressive therapies in CMV reactivation and, as expected, corticosteroid-based therapy was linked with an increased risk of CMV-associated colitis [15,17,19,20,22,23,24,25], whereas anti-tumor necrosis factor (TNF)-alpha administration was not [26,27,28].